Nathan Connell: Calling All Hematology Professionals Interested in Quality Improvement!
Nathan Connell, Clinical Chief of Hematology at Brigham and Women’s Faulkner Hospital, shared on LinkedIn:
”Calling All Hematology Professionals Interested in Quality Improvement!
The application window is OPEN for the American Society of Hematology (ASH) Quality Improvement Training Institute (QITI)—a phenomenal, 16-month hybrid program designed to build clinician leadership and drive systems-based change in hematologic care.
This is a must for anyone looking to advance their career in systems-based hematology and become a leader in quality improvement.
Why QITI stands out:
- Hands-on Experience: Teams work on two structured QI projects at their home institution, directly addressing clinical gaps and enhancing patient experience, outcomes, and equity.
- Expert Coaching: Each team is paired with an experienced QI coach for individualized, 16-month mentorship.
- Free to Participate: ASH covers travel, lodging, and meal expenses for up to three team members attending the mandatory in-person workshops in Washington, DC.
QITI is designed for interdisciplinary care teams in North America. If you are passionate about continuous improvement and want to formally integrate QI methodology into your practice, this is your chance!
The 2026-2027 application closes January 5, 2026.
Learn more and apply here.”
Stay updated on all opportunities with Hemostasis Today.
-
Oct 9, 2025, 06:44Gretchen Simmons: Anyone Can Have a Blood Clot - No One Knows This Better Than Carol West
-
Oct 8, 2025, 03:07Stroke Education By Rodrigo Guerrero - On Unilateral, Nonprogressive Stenosis
-
Oct 7, 2025, 15:015 Simple Exercises By Christina P. That Support Health in Antiphospholipid Syndrome
-
Oct 7, 2025, 14:39Dr Amid Karad: Help Raise Awareness on Evidence-Based INR Management for Diverse Indications
-
Oct 7, 2025, 14:27NBCA Insights with Erin VanDyke: Revealing Gaps in Blood Clot Diagnosis and Support
-
Oct 9, 2025, 07:14Ami Bhatt: The link Between Inflammation and Atherosclerotic Cardiovascular Disease Is No Longer Theoretical
-
Oct 9, 2025, 06:59Courtney Lawrence: It's Critical That as Blood Donor Eligibility Criteria Evolves
-
Oct 9, 2025, 06:55All You Need to Know About Generative AI in Medicine from Daniel Ting and Colleagues
-
Oct 9, 2025, 06:52Cihan Ay and Colleagues on Large Language Models VS Thrombosis Experts
-
Oct 9, 2025, 06:48A Neopoterian Theory of Global Bioethics from Henri-Corto Stoeklé and Christian Hervé
-
Oct 7, 2025, 13:06Bobur Kholikov on iFlash Thrombosis Panel – D-Dimer
-
Oct 7, 2025, 03:502025 Nobel Prize: A Milestone for Autoimmunity Research - Awarded to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi
-
Oct 3, 2025, 15:31Anirban Sen Gupta and Andrew Shoffstall Collaboration on Bioinspired Synthetic Platelet Systems for Brain Injury Treatment
-
Oct 3, 2025, 15:07Shai Shen-Orr: Excited to Share that The Human Immunome Project (HIP) Has Launched Its Scientific Partner Network
-
Oct 2, 2025, 04:59Caterina Casari - Prizes for Innovators 2025 Winner!
-
Oct 9, 2025, 07:15Hema Tallman: Imagine Needing A Treatment So Rare, So Specific, That Only Plasma-derived Medicine Can Help
-
Oct 9, 2025, 07:07Rahaf Ajaj: It’s About How Deeply Your Idea Can Reshape The World
-
Oct 8, 2025, 04:45Reza Shojaei: On The 2nd Day of IPAW 2025, Let's Focus on Patients, The Real Reason Plasma Matters!
-
Oct 7, 2025, 08:29“48 Poems on 48 Blood Group Systems” - Dr Bhavyaa Beriwal Blends Science and Poetry in Her New Transfusion Medicine Book
-
Oct 7, 2025, 04:35Hema Tallman: During IPAW, We Honor The Unseen Heroes – Plasma Donors